Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy
Bethsebie Lalduhsaki Sailo,Suravi Chauhan,Mangala Hegde,Sosmitha Girisa,Mohammed S. Alqahtani,Mohamed Abbas,Arul Goel,Gautam Sethi,Ajaikumar B. Kunnumakkara
DOI: https://doi.org/10.1002/ptr.8131
IF: 6.388
2024-02-16
Phytotherapy Research
Abstract:Chemoresistance is the adaptation of cancer cells against therapeutic agents. When exhibited by cancer cells, chemoresistance helps them to avoid apoptosis, cause relapse, and metastasize, making it challenging for chemotherapeutic agents to treat cancer. Various strategies like dosage modification of drugs, nanoparticle‐based delivery of chemotherapeutics, antibody‐drug conjugates, and so on are being used to target and reverse chemoresistance, one among such is combination therapy. It uses the combination of two or more therapeutic agents to reverse multidrug resistance and improve the effects of chemotherapy. Phytochemicals are known to exhibit chemosensitizing properties and are found to be effective against various cancers. Tocotrienols (T3) and tocopherols (T) are natural bioactive analogs of vitamin E, which exhibit important medicinal value and potential curative properties apart from serving as an antioxidant and nutrient supplement. Notably, T3 exhibits a variety of pharmacological activities like anticancer, anti‐inflammatory, antiproliferative, and so on. The chemosensitizing property of tocotrienol is exhibited by modulating several signaling pathways and molecular targets involved in cancer cell survival, proliferation, invasion, migration, and metastasis like NF‐κB, STATs, Akt/mTOR, Bax/Bcl‐2, Wnt/β‐catenin, and many more. T3 sensitizes cancer cells to chemotherapeutic drugs including cisplatin, doxorubicin, and paclitaxel increasing drug concentration and cytotoxicity. Discussed herewith are the chemosensitizing properties of tocotrienols on various cancer cell types when combined with various drugs and biological molecules.
pharmacology & pharmacy,chemistry, medicinal